Advertisement

Topics

NVO INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Novo Nordisk A/S

16:05 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased or ...

Other Sources for this Article

Contact for Media Inquiries Only
Lieff Cabraser Heimann & Bernstein, LLP
Sharon M. Lee, 1-800-541-7358

NEXT ARTICLE

More From BioPortfolio on "NVO INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Novo Nordisk A/S"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...